Touted as an alternative to opioid painkillers since its 2017 approvals in the U.S. and Europe, the devicemaker’s Intellis spinal cord stimulator demonstrated it could cut reported back pain by at ...
Medtronic delivered new clinical data demonstrating improved relief from chronic pain using a modified, low-power version of its spinal cord stimulation therapy, potentially enabling fewer recharges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results